Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma.
about
Systemic manifestations of hepatitis C infectionPolyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents.Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma.HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
P2860
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sofosbuvir-based therapy cures ...... ient with concurrent lymphoma.
@en
type
label
Sofosbuvir-based therapy cures ...... ient with concurrent lymphoma.
@en
prefLabel
Sofosbuvir-based therapy cures ...... ient with concurrent lymphoma.
@en
P50
P1476
Sofosbuvir-based therapy cures ...... tient with concurrent lymphoma
@en
P2093
Alessandra Marrazzo
Dante Romagnoli
P356
10.1016/J.JCV.2015.05.023
P577
2015-05-30T00:00:00Z